Down syndrome with neonatal alloimmune thrombocytopenia due to anti-HLA A31 and B61 antibodies. 2021

Eriko Shima, and Hayato Go, and Hajime Maeda, and Kei Ogasawara, and Takashi Imamura, and Mutsumi Sasaki, and Yangsook Koh, and Kenneth E Nollet, and Kazuhiko Ikeda, and Hitoshi Ohto, and Mitsuaki Hosoya
Department of Pediatrics, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan.

Neonatal alloimmune thrombocytopenia (NAIT) arises from fetomaternal platelet incompatibility that results in transplacental passage of maternal antibodies mostly against fetal human platelet antigens (HPA), whereas NAIT due to anti-human leukocyte antigen (HLA) antibodies is extremely rare. Here, we report a case of Down syndrome (DS) with NAIT that was attributed to HLA antibodies. A boy with DS was delivered at 36 weeks' gestation. His platelet count declined to 13.0 × 109/L, suggestive of NAIT rather than other conditions, including transient abnormal myelopoiesis. Random platelet concentrates and intravenous immunoglobulin administration resolved the thrombocytopenia without clinical complications. Immunoserological investigations detected anti-HLA, but no anti-HPA antibodies in samples from the patient and the mother. HLA typing and cross-matching indicated that anti-HLA antibodies to paternal HLA A31 and B61, which had probably been induced during a prior pregnancy, led to NAIT in this case. Although it is a rare condition, healthcare providers should consider NAIT due to HLA antibodies and be vigilant for subsequent cases in DS.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D008297 Male Males
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D015234 HLA-A Antigens Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts. Antigens, HLA-A,HLA-A,Antigens, HLA A,HLA A Antigens
D015235 HLA-B Antigens Class I human histocompatibility (HLA) surface antigens encoded by more than 30 detectable alleles on locus B of the HLA complex, the most polymorphic of all the HLA specificities. Several of these antigens (e.g., HLA-B27, -B7, -B8) are strongly associated with predisposition to rheumatoid and other autoimmune disorders. Like other class I HLA determinants, they are involved in the cellular immune reactivity of cytolytic T lymphocytes. Antigens, HLA-B,HLA-B Antigen,HLA-B,Antigen, HLA-B,Antigens, HLA B,HLA B Antigen,HLA B Antigens

Related Publications

Eriko Shima, and Hayato Go, and Hajime Maeda, and Kei Ogasawara, and Takashi Imamura, and Mutsumi Sasaki, and Yangsook Koh, and Kenneth E Nollet, and Kazuhiko Ikeda, and Hitoshi Ohto, and Mitsuaki Hosoya
January 1986, Current studies in hematology and blood transfusion,
Eriko Shima, and Hayato Go, and Hajime Maeda, and Kei Ogasawara, and Takashi Imamura, and Mutsumi Sasaki, and Yangsook Koh, and Kenneth E Nollet, and Kazuhiko Ikeda, and Hitoshi Ohto, and Mitsuaki Hosoya
July 1990, Ceskoslovenska pediatrie,
Eriko Shima, and Hayato Go, and Hajime Maeda, and Kei Ogasawara, and Takashi Imamura, and Mutsumi Sasaki, and Yangsook Koh, and Kenneth E Nollet, and Kazuhiko Ikeda, and Hitoshi Ohto, and Mitsuaki Hosoya
January 2004, Acta haematologica,
Eriko Shima, and Hayato Go, and Hajime Maeda, and Kei Ogasawara, and Takashi Imamura, and Mutsumi Sasaki, and Yangsook Koh, and Kenneth E Nollet, and Kazuhiko Ikeda, and Hitoshi Ohto, and Mitsuaki Hosoya
January 2015, Fukushima journal of medical science,
Eriko Shima, and Hayato Go, and Hajime Maeda, and Kei Ogasawara, and Takashi Imamura, and Mutsumi Sasaki, and Yangsook Koh, and Kenneth E Nollet, and Kazuhiko Ikeda, and Hitoshi Ohto, and Mitsuaki Hosoya
May 2002, Archives of disease in childhood. Fetal and neonatal edition,
Eriko Shima, and Hayato Go, and Hajime Maeda, and Kei Ogasawara, and Takashi Imamura, and Mutsumi Sasaki, and Yangsook Koh, and Kenneth E Nollet, and Kazuhiko Ikeda, and Hitoshi Ohto, and Mitsuaki Hosoya
January 1992, Acta haematologica,
Eriko Shima, and Hayato Go, and Hajime Maeda, and Kei Ogasawara, and Takashi Imamura, and Mutsumi Sasaki, and Yangsook Koh, and Kenneth E Nollet, and Kazuhiko Ikeda, and Hitoshi Ohto, and Mitsuaki Hosoya
August 2002, International journal of hematology,
Eriko Shima, and Hayato Go, and Hajime Maeda, and Kei Ogasawara, and Takashi Imamura, and Mutsumi Sasaki, and Yangsook Koh, and Kenneth E Nollet, and Kazuhiko Ikeda, and Hitoshi Ohto, and Mitsuaki Hosoya
June 2023, Transfusion,
Eriko Shima, and Hayato Go, and Hajime Maeda, and Kei Ogasawara, and Takashi Imamura, and Mutsumi Sasaki, and Yangsook Koh, and Kenneth E Nollet, and Kazuhiko Ikeda, and Hitoshi Ohto, and Mitsuaki Hosoya
March 2001, Transfusion,
Eriko Shima, and Hayato Go, and Hajime Maeda, and Kei Ogasawara, and Takashi Imamura, and Mutsumi Sasaki, and Yangsook Koh, and Kenneth E Nollet, and Kazuhiko Ikeda, and Hitoshi Ohto, and Mitsuaki Hosoya
January 2003, Immunohematology,
Copied contents to your clipboard!